APA (7th ed.) Citation

Kuan, J., Chang, K., Lau, N. S., Visalachy, P., Tan, S. M., Ong, T. C., & Su, A. (2011). The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms. Elsevier Ltd.

Chicago Style (17th ed.) Citation

Kuan, Jew-Win, Kian-Meng Chang, Ngee Siang Lau, Purushothaman Visalachy, Sen Mui Tan, Tee Chuan Ong, and Anselm-Ting Su. The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms. Elsevier Ltd, 2011.

MLA (9th ed.) Citation

Kuan, Jew-Win, et al. The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms. Elsevier Ltd, 2011.